Dr. William T. Tse
Claim this profileMetroHealth Medical Center
Studies Lung Cancer
Studies Breast Cancer
49 reported clinical trials
117 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage II
Stage I
2Breast Cancer
HER2 positive
Stage II
Stage I
Affiliated Hospitals
Clinical Trials William T. Tse is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting2 awards Phase 310 criteria
More about William T. Tse
Clinical Trial Related8 years of experience running clinical trials · Led 49 trials as a Principal Investigator · 13 Active Clinical TrialsTreatments William T. Tse has experience with
- Nivolumab
- Cisplatin
- Paclitaxel
- Ipilimumab
- Atezolizumab
- Pembrolizumab
Breakdown of trials William T. Tse has run
Lung Cancer
Breast Cancer
Breast cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William T. Tse specialize in?
William T. Tse focuses on Lung Cancer and Breast Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is William T. Tse currently recruiting for clinical trials?
Yes, William T. Tse is currently recruiting for 13 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that William T. Tse has studied deeply?
Yes, William T. Tse has studied treatments such as Nivolumab, Cisplatin, Paclitaxel.
What is the best way to schedule an appointment with William T. Tse?
Apply for one of the trials that William T. Tse is conducting.
What is the office address of William T. Tse?
The office of William T. Tse is located at: MetroHealth Medical Center, Cleveland, Ohio 44109 United States. This is the address for their practice at the MetroHealth Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.